Glycosidase inhibitors and uses thereof
US9938299B2 · kind B2 · utility
5Cited by
8References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 20, 2013 |
| Grant date | Apr 10, 2018 |
| Priority date | — |
| Expiry date | Jan 10, 2034 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB65D2571/00716
- WIPO fieldHandling
- WIPO sectorMechanical engineering
Abstract
The invention provides compounds with enhanced permeability for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.